Our goal is to make predictive medicine accessible to all
“When I was teaching mathematics applied to medicine and working at the Gustave Roussy cancer centre, I would see patients in the lobby and wonder whether we could have anticipated these diseases. The idea of predicting risks to find the best way of preventing them was thus born.”
Chief Executive Officer
Founded in 2004, Predilife, a pioneer of predictive medicine in France, designs and markets predictive tests, giving everyone the chance to find out their own risk of developing serious diseases.
It combines proven medical techniques with Artificial Intelligence and Big Data.
Predictive medicine involves anticipating an individual’s future so that action can be taken in time thanks to personalised prevention, either by reducing risk, or by identifying the disease as early as possible.
Serious conditions, such as cancer and heart attack, can now be better prevented.
After 14 years of research and development, Predilife obtained its medical device certification and launched predictive check-ups on the French and international market: predictive check-up for breast cancer, predictive check-ups for multiple conditions. Since 2018, Predilife has been listed on Euronext Growth.
We believe that predictive medicine will lead to effective prevention and thus reduce the risk of serious disease.
We believe that each individual should play a key role in their own health and benefit from personalised medical follow-up.Discover our solutions